I'm new to this board, but an investor since Novem
Post# of 15624
While I believe the results are tremendous, I'm unsure if in israel or elsewhere if they're going for approval as a drug, or if the cream meets the requirements to be marketed where other marijuana based products can be marketed already.
I believe the company's approach to marketing in the U.S. is clearly as a cosmetic product, not requiring an FDA approval for efficacy. I believe that what they've done in excess of many products sold in Green Cross stores is to run a safety trial which can be found in the FDA clinical trials database. I believe this is the same trial that the IRB recently approved in Israel, it's being done with people who have no medical need for the cream, so it's purely intended to prove the cream safe.
I don't have psoriasis per se, but I have used drugs like Clobetasol which is a topical steroid cream that helps with psoriasis. The problem with this, and many other topical creams available by prescription by prescription, or over the counter like Hydrocortisone, is that their are side effects that don't permit them to be used too frequently. That caution came from my dermatologist who wrote the various prescriptions.
If in fact the psoriasis cream from OWCP has no, or less in the way of side effects than say hydrocortisone which is a steroid available without a prescription, it could have a tremendous market. The release by OWCP indicated that additional double blind testing will be undertaken with other skin diseases, like acne. A poster on I-H indicated that some of the patients in the efficacy trials did have other skin diseases, so the company has at least some anecdotal evidence that it's effective in skin diseases well beyond psoriasis.
Gary